Duration of diabetes and cardiorenal efficacy of liraglutide and semaglutide: A post hoc analysis of the LEADER and SUSTAIN 6 clinical trials
Date first appeared online 09/03/2019
DOI 10.1111/dom.13698
Authors Bain S.
Journal Name Diabetes, Obesity and Metabolism
Volume 21

Documents
  • 50827.pdf , Book, Released under the terms of a Creative Commons Attribution-NonCommercial License (CC-BY-NC).